Subscribe to our RSS feeds RSS    
 

 Bladder Cancer Articles

When to Use Intravesical Therapies

Kris E. Gaston, MD, Ashish M. Kamat, MD May 08, 2007

BLADDER CANCER is projected to be the fourth most common cancer diagnosed in 2007 and the eighth most common cause of cancer-specific death in men, according to the American Cancer Society. Approximately 70% of bladder tumors present as non-muscle invasive (NMI) disease and 10%-20% will progress to muscle invasion.
 

Bladder Cancer Drug R&D Falls Short

Noelle Holly, MD May 04, 2007

A principal reason for poor outcomes among bladder cancer patients is metastatic disease during follow-up. With currently available drugs, metastatic disease to other solid organs is only curable in less than 10% of patients, according to Virginia urologist Dan Theodorescu, MD, PhD.
 

High-Risk Bladder Cancer Management

Colin P.N. Dinney, MD May 04, 2007

Bladder cancer caught early is often amenable to treatment, but of course late-stage and aggressive characteristics alter the prognosis for the worse. Understanding high-risk features, including aberrant histologic patterns, empowers the urologist to counsel and treat patients with greater precision.
 

High-Risk Bladder Cancer Management

Colin P.N. Dinney, MD April 25, 2007

Bladder cancer caught early is often amenable to treatment, but of course late-stage and aggressive characteristics alter the prognosis for the worse. Understanding high-risk features, including aberrant histologic patterns, empowers the urologist to counsel and treat patients with greater precision.
 

Colitis After Cystectomy

Jody A. Charnow March 01, 2007

A study of patients who experienced Clostridium difficile colitis (CDC) following cystectomy found that the infection did not significantly affect patients’ hospital course.
 

Hydronephrosis Is An Ominous Sign

Jody A. Charnow March 01, 2007

HYDRONEPHROSIS at the diagnosis of bladder cancer is a significant prognostic marker for advanced malignancy, according to German researchers.
 

TCC Plus Variant Histology Reduces Treatment Response

Jody A. Charnow March 01, 2007

Variant tumor histology in patients with transitional cell carcinoma (TCC) is an indication for neoadjuvant chemotherapy, according to researchers
 

Age Affects Immunotherapy Response

Jody A. Charnow October 01, 2006

ADVANCED AGE is associated with a diminished response to intravesical therapy for superficial bladder cancer, a study found.
 

Antibiotic May Ease Adverse Effects of BCG

Jody A. Charnow October 01, 2006

PROPHYLAXIS with ofloxacin decreases the incidence of moderate-to-severe adverse effects from bacillus Calmette-Guérin (BCG) intravesical therapy in patients with superficial bladder cancer, French researchers reported. Ofloxacin is a fluoroquinolone with tuberculostatic properties.
 
 
A Haymarket Media, Inc website
Home | News | Departments | Editorial Board | Contact | Subscribe | Advertise | About
From Haymarket Medical the Publishers of:
Monthly Prescribing Reference Nurse Practitioners' Prescribing Reference Physician Assistants' Prescribing Reference
Cortlandt Forum McKnight's Long-Term Care News Renal & Urology News The Clinical Advisor JAAPA McKnight's Assisted Living